RecruitingNCT06943729

Clinical Safety and Efficacy of Flow-diverter in the Treatment of Intracranial Aneurysms

Clinical Safety and Efficacy of Flow Diverter in the Treatment of Intracranial Aneurysms


Sponsor

Huashan Hospital

Enrollment

523 participants

Start Date

Apr 27, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

To collect the safety and effectiveness data of flow-di in the treatment of intracranial aneurysms in real-world clinical practice, verify its classification of treatment strategies for aneurysms of different locations and shapes, and optimize postoperative medication regimen, provide long-term evidence-based basis for clinical treatment of intracranial aneurysms, and build a database.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with flow diverter. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Huashan hospital

Shanghai, Shanghai Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06943729


Related Trials